Summary: GLP-1 receptor agonists may reduce inflammation by decreasing pro-inflammatory cytokines, modulating immune signalling pathways, and indirectly through weight loss and improved metabolic health
Pills might accelerate your weight loss, but diet patches the holes that keep hair, skin, and body fit
Amylin receptors are considered proven drug targets and amylin mimetics are emerging as novel treatments for overweight, obesity and diabetes mellitus
Zudem sind mgliche Langzeitfolgen kaum erforscht
If approved, it would represent a significant milestone, becoming the first oral GLP-1 treatment specifically for obesity with an efficacy profile on par with the most potent injectables
How strong is the published evidence on fasting while using GLP-1 medications